We evaluated a new thyroxin analog-based assay for free thyroxin (FT4) (Corning Medical), finding it technically simple and precise (between-assay CVs of 3.3 and 4.2% for FT4
TBG is not the only protein binding T4 in serum, the product of total T4 times 1ITBG concentration imprecisely reflects the concentration of Fr4.
Another approach to estimating the association of T4 with serum proteins involves the use of anti-T4 antibody. As initially proposed by Odstrchel assays involving synthetic thyroxin analogs (6). The analog assays are technically simpler because they require no separation of the antibody-labeled analog product from the patient's serum protein binders before quantification.
We describe here our experience with a new assay for Fr4 from Corning Medical [Immophase"
Single
Step Free T4 (125-I) Radioimmunoassayl, in which are used anti-T4 antibody bound to a solid phase (pourous glass) and a radiolabaled thyroxin analog that is recognized by the antibody but not by the thyroxin-binding proteins in serum.2
Materials and Methods

Kits and Procedures
We used the following commercially available RIA kits during this study: FT4-Corning: Rabbit antibody toT4 is covalently bound to porous glass beads. Add 50 p.L of serum sample, 200 L of E125llthyroxin analog, and 500 L of antibody slurry (provided in the kit) to the assay tube, incubate for 1 h at 37 #{176}C, centrifuge (2200 x g, 10 mm), decant, and count the radioactivity associated with the beads. The concentration of VP4 in the unknown is estimated by relating the antibody-associated activity to similarly treated VP4 calibrators, the Fl'4 concentration of which has been determined by equilibrium dialysis.
FT4-Amersham (Amerlex, Amersham Corp., Arlington Heights, IL 60005). We established reference intervals for this assay during this study (see below).
Total serum T4 (Nuclear Medical Laboratories, Irvine, TX 75061): reference interval in euthyroid subjects, 45-115 gfL.
(T3) uptake (Nuclear Medical Laboratories): reference interval 35-45%.
both comparing well with those of the Amersham analogbased assay for FT4 (7) . The reference interval, 10-23 ngfL, clearly differentiated untreated hyper-and hypothyroid from euthyroid patients, only six of 74 results for euthyroid 2This assay is not to be confused with the original Immophase" kit for FF4, which also included a glass bead/antibody solid phase, or with the magnetic particle ("MAGIC") FF4 assay also currently marketed by Corning Medical. 49 euthyroid, pregnant; 33 hypothyroid, of whom 22 were untreated primary, 10 were inadequately treated (abovenormal thyrotropin), and one was secondary; 29 hyperthyroid, of whom 17 were untreated primary and 12 factitial; 45 non-thyroidally ill; and 43 patients receiving drugs known to interfere with protein binding of T4, including 13 receiving phenytoin, 12 receiving heparin, and 18 receiving salicylate. One additional patient with unusual T4 binding (increased albumin binding, demonstrated by electrophoresis) was also studied. We established normal reference intervals for the two FT4 assays based on the data from these patients. We used the same patient population to establish reference intervals for both assays, choosing values that detected 100% of the untreated hyper-and hypothyroid same two control pools were 3.3% and 4.2%, respectively. Figure 2 shows the VP4-Corning results for euthyroid patients, non-thyroidally ill patients, and hyper-and hypothyroid patients. We chose a normal reference interval of 10-23 ngfL based on these data. We express our appreciation to Corning Medical, who provided their reagentskits used in this study. 
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Anion-Exchange Chromatographic Determination of Bromide in Serum
Marvin E. Miller1and Chris J. Cappon2
In this liquid-chromatographic method for the determination of bromide in human serum, an important and unique feature is pre-analysis ultrafiltration of the sample, which effectively removes proteins. The chromatographic system consists of an anion-exchange column (Whatman Partisil SAX 10-sm particles), an isocratic phosphate-buffered mobile phase, and ultraviolet detection at 195 nm. The absolute detection limit, 0.6 ng of bromide, makes this method the most sensitive assay for serum bromide yet reported. The day-to-day CV ranged from 1.6% to 4.9%. Analytical recovery of bromide added to serum samples ranged from 96.2% to 108.8%. Data on bromide in serum are presented for adults and newborns and for adults given bromide orally.
AddItIonal Keyphrases: halogens . newborns . drug assay pediatric chemistry . measurements of extracellular volume Inorganic bromide salts were originally used in the treatment of syphilis over a century ago, were later used as anticonvulsants, and more recently have been common ingredients in nonprescription sedative preparations. The need has thus arisen for monitoring bromide concentrations in serum.
Several analytical techniques have been reported for bromide determination in biological fluids. Each has significant drawbacks. Titrimetric methods are laborious and time consuming, and lack sufficient sensitivity. Colonmetric methods also lack the desired sensitivity. Both x-ray fluorescence and neutron activation techniques are expensive and not widely available. Gas-chromatographic procedures require derivatization, and conductimetry is restricted by the requirement for selected eluents, which must be made nonconducting by ion-suppression. A recent major advance in analysis for bromide in aqueous solutions involves the use of "high-performance" liquid chromatography in the reversed-phase separation mode, coupled with detection in the far ultraviolet region (<220 nm). Cortes (1) described a procedure involving a Zorbax amino column, a 30 mmolIL H2S04 mobile phase, and detection of 205 nm, for which the bromide sensitivity was 0.5 mg/L. Molnar et al. (2) used a LiChrosorb RP-18 column with a phosphate-tetrabutylammonium chloride mobile phase and a conductivity detector; they did not speci the bromide detection limit, but it appeared to be in the high nanogram range.
Ion-pair reversed-phase liquid chromatography has also been successfully applied to the analysis of bromide in aqueous solution. Reeve (3) used a cyano-bonded silica column, a methanolic phosphate buffer containing 1 g of cetyltrimethylammonium bromide per liter, and detection at 215 nm; the sensitivity for bromide was 60 ng. deKleijn (4) was able to improve the sensitivity to 0.6 mg/L, by using a cyano column with an acetonitrile/phosphate buffer containing 1 g of hexadecyltrimethylammonium chloride per liter and 205 nm detection. Both of these procedures necessitated a rather long column equilibration, usually 50-150 column volumes, with the mobile phase.
These methods were used for bromide and other inorganic and organic anions in aqueous solution. Mobile-phase flow rates were relatively high, 2 to 3 mL/min. Bromide was effectively separated from other anions, but none of the authors assessed the extent to which chloride ion interfered with bromide separation and analysis. Such information is critical in serum bromide determination because of serum's relatively high chloride content, 3.5 g/L (Cl:Br ratio >5000:1).
Recently, Stetzenbach and Thompson (5) described an ionexchange chromatographic technique in which bromide was well separated from other anions, including chloride, in ground water. Their use of phosphate buffer provided satisfactory resolution of both ions, and the detection limit for
